Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-414-0 | CAS number: 814-94-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2011
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- stannous sulphate
- IUPAC Name:
- stannous sulphate
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- mammalian cell line, other: ncultured human peripheral blood lymphocytes
- Additional strain / cell type characteristics:
- other: female
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9
- Test concentrations with justification for top dose:
- 0.2500 - 300 µg/mL (> 40 different doses)
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- Remarks:
- without S9
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- cyclohexylamine
- Remarks:
- with S9
Results and discussion
Test resultsopen allclose all
- Species / strain:
- mammalian cell line, other: cultured human peripheral blood lymphocytes
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- mammalian cell line, other: cultured human peripheral blood lymphocytes
- Metabolic activation:
- without
- Genotoxicity:
- ambiguous
- Remarks:
- negative for 3+17hr; positive for 20+0 hr
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Stannous Sulfate, crystalline was tested in an in vitro cytogenetics assay using duplicate human lymphocyte cultures prepared from the pooled blood of three female donors in two independent experiments. Treatments covering a broad range of concentrations, separated by narrow intervals, were performed both in the absence and presence of metabolic activation (S-9) from Aroclor 1254 induced animals. The test article was formulated in water for irrigation (purified water). The highest concentrations used in the Main Experiments were limited by toxicity and were determined following preliminary cytotoxicity Range-Finder Experiments. Treatments were conducted (as detailed in the following summary tables) 48 hours following mitogen stimulation by phytohaemagglutinin (PHA). The test article concentrations for chromosome analysis were selected by evaluating the effect of Stannous Sulfate, crystalline on mitotic index. In each experiment, chromosome aberrations were analysed at three or four concentrations.
Appropriate negative (vehicle) control cultures were included in the test system in both experiments under each treatment condition. The proportion of cells with structural aberrations (excluding gaps) in these cultures fell within current historical vehicle control (normal) ranges. 4-Nitroquinoline 1-oxide (NQO) and cyclophosphamide (CPA) were employed as positive control chemicals in the absence and presence of rat liver S-9 respectively. Cells receiving these were sampled in each experiment, 20 hours after the start of treatment; both compounds induced statistically significant increases in the proportion of cells with structural aberrations. All acceptance criteria were considered met and the study was accepted as valid. Treatment of cells with Stannous Sulfate, crystalline for 3+17 hours in the absence of S-9 in Experiment 1 resulted in frequencies of cells with structural aberrations that were generally similar to those observed in concurrent vehicle control cultures. Numbers of aberrant cells (excluding gaps) fell within the 95th percentile of the observed range (0-3% aberrant cells) with the exception of one culture at the highest concentration analysed (5.000 μg/mL) in which 6% aberrant cells were observed, which fell outside the observed range of 0-4%. Treatment of cells for 20+0 hours in the absence of S-9 in Experiment 2 resulted in frequencies of cells with structural aberrations that were significantly higher (p ≤ 0.01) than those observed in concurrent vehicle control cultures at the highest two concentrations analysed (4.500 and 5.000 μg/mL, giving 42% and 57% mitotic inhibition, respectively). Numbers of aberrant cells (excluding gaps) exceeded the 95th percentile of the observed range in both cultures at 5.000 μg/mL and in single cultures at 4.000 and 4.500 μg/mL. The Experiment 2 data fulfilled the criteria for a positive result. Treatment of cells for 3+17 hours in the presence of S-9 in Experiment 1 resulted in frequencies of cells with structural aberrations that were slightly elevated, compared to those observed in concurrent vehicle control cultures, at all concentrations analysed. Numbers of aberrant cells (excluding gaps) exceeded the 95th percentile of the observed range (0-3% aberrant cells) in single cultures at all three concentrations analysed (7%, 6% and 5% at 80.00, 130.0 and 200.0 μg/mL, respectively). The aberrant cell frequencies (excluding gaps) in the replicate cultures at all three concentrations fell within the 95th percentile of the observed range, but the mean aberration frequencies exceeded the 95th percentile of the observed range at 80.00 and 200.0 μg/mL. These data were considered equivocal when viewed in isolation. Treatment of cells for 3+17 hours in the presence of S-9 in Experiment 2 resulted in frequencies of cells with structural aberrations that were significantly higher (p ≤ 0.001) than those observed in concurrent vehicle control cultures at the highest three concentrations analysed (100.0, 140.0 and 160.0 μg/mL, giving 39%, 53% and 57% mitotic inhibition, respectively). Numbers of aberrant cells (excluding gaps) exceeded the 95th percentile of the observed range in both cultures analysed at these concentrations. The Experiment 2 data fulfilled the criteria for a positive result, thus substantiating the result observed in Experiment 1 under this treatment condition. No increases in the frequency of cells with numerical aberrations, which exceeded the concurrent controls and the normal ranges, were observed in cultures treated with Stannous Sulfate, crystalline in the absence and presence of S-9 in Experiments 1 and 2. It is concluded that Stannous Sulfate, crystalline induced structural chromosome aberrations in cultured human lymphocyte cells when tested for 3+17 hours in the presence of S-9 and for 20+0 hours in the absence of S-9. In the same test system, Stannous Sulfate, crystalline did not induce structural chromosome aberrations when tested up to toxic concentrations for 3+17 hours in the absence of S-9..
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
positive with metabolic activation
ambiguous without metabolic activation negative for 3+17hr; positive for 20+0 hr
It is concluded that Stannous Sulfate, crystalline induced structural chromosome aberrations in cultured human lymphocyte cells when tested for 3+17 hours in the presence of S-9 and for 20+0 hours in the absence of S-9. In the same test system, Stannous Sulfate, crystalline did not induce structural chromosome aberrations when tested up to toxic concentrations for 3+17 hours in the absence of S-9.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.